Viewing Study NCT00618995


Ignite Creation Date: 2025-12-24 @ 2:20 PM
Ignite Modification Date: 2026-01-02 @ 8:46 AM
Study NCT ID: NCT00618995
Status: COMPLETED
Last Update Posted: 2015-09-07
First Post: 2008-02-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)
Sponsor: Merck Sharp & Dohme LLC
Organization: